~~<i id='213274C46C'><strike id='213274C46C'><tt id='213274C46C'><pre id='213274C46C'></pre></tt></strike></i>~~

Home» explore» explore

explore

author：hotspot 2025-09-30 08:22:42 Page View：9375

HHS 2020 — PhRMA is suing the Biden administration over its new Medicare drug price negotiation program. Graeme Sloan/Sipa USA

WASHINGTON — After losing the drug pricing fight on Capitol Hill, PhRMA is taking its battle to the courts.

The pharmaceutical industry’s biggest lobbying group on Wednesday filed a long-expected lawsuit challenging Democrats’ drug pricing law that allowed Medicare to start negotiating prices for certain medicines.

PhRMA joins a growing club of companies and trades challenging the law. Merck, Bristol Myers Squibb, and the Chamber of Commerce have already filed similar suits in different courts.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Health AI adoption puts security, privacy startups on investors' radar
Next article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

knowledge

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

6:16PresidentJoeBidenspeaksintheRooseveltRoomoftheWhiteHouse,June30,2023.EvanVucci/APPresidentJoeBid

Intermittent fasting comes with a heart risk? Not so fast

AdobeThenewsiseverywhereinmysocialnewsfeedsthismorning:Apopularfaddietisapparentlylethal,scientificr

New air purifier tech could be key to improving indoor air quality

AdobeUntiltheearly20thcentury,Americaregularlyexperiencedbrutallydestructiveurbanfires.Conflagration

Readout Newsletter: Bluebird, CVS, Contineum

JustinSullivan/GettyImagesWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetour